OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
Lang Rao, Shuai Xia, Wei Xu, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 44, pp. 27141-27147
Open Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

Recent applications of immunomodulatory biomaterials for disease immunotherapy
Huaxing Dai, Qin Fan, Chao Wang
Exploration (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 182

Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine
Zhenzhen Wang, Kristen D. Popowski, Dashuai Zhu, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 7, pp. 791-805
Open Access | Times Cited: 181

Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19
Zhenhua Li, Zhenzhen Wang, Phuong‐Uyen Dinh, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 8, pp. 942-951
Open Access | Times Cited: 137

Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
Qi Qiao, Xiong Liu, Ting Yang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3060-3091
Open Access | Times Cited: 120

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities
Bethany Claridge, Jonathan Lozano, Qi Hui Poh, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 119

White Blood Cell Membrane‐Coated Nanoparticles: Recent Development and Medical Applications
Dan Wang, Shuyan Wang, Zhidong Zhou, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 7
Closed Access | Times Cited: 116

Nanotechnology-based strategies against SARS-CoV-2 variants
Xiangang Huang, Edo Kon, Xuexiang Han, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 10, pp. 1027-1037
Open Access | Times Cited: 102

Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Zhaoting Li, Yixin Wang, Yingyue Ding, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 23
Closed Access | Times Cited: 101

Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Gavin Y. Oudit, Kaiming Wang, Anissa Viveiros, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 906-922
Open Access | Times Cited: 74

Immuno‐Engineered Nanodecoys for the Multi‐Target Anti‐Inflammatory Treatment of Autoimmune Diseases
Mengying Hou, Yuansong Wei, Ziyin Zhao, et al.
Advanced Materials (2022) Vol. 34, Iss. 12
Closed Access | Times Cited: 71

Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine
Marjorie C. Zambonino, Ernesto Mateo Quizhpe, Lynda Mouheb, et al.
Nanomaterials (2023) Vol. 13, Iss. 3, pp. 424-424
Open Access | Times Cited: 64

Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
Qian‐Fang Meng, Wanbo Tai, Mingyao Tian, et al.
Science Advances (2023) Vol. 9, Iss. 24
Open Access | Times Cited: 57

Boosting Checkpoint Immunotherapy with Biomaterials
Lujie Liu, Yuanwei Pan, Chenchen Zhao, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 3225-3258
Closed Access | Times Cited: 55

Engineered Living Materials for Advanced Diseases Therapy
Dong Xue, Wei Wu, Pei Pan, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 48

Translational medicine for acute lung injury
Jianguo Zhang, Yumeng Guo, Michael Mak, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25

Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
Qian‐Fang Meng, Yuyue Zhao, Chunbo Dong, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 50, pp. 26320-26326
Closed Access | Times Cited: 85

Application of Nanotechnology in the COVID-19 Pandemic
Dongki Yang
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 623-649
Open Access | Times Cited: 81

Extracellular vesicles as delivery systems at nano-/micro-scale
Peiwen Fu, Jianguo Zhang, Haitao Li, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113910-113910
Open Access | Times Cited: 80

Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone
Cheng Wang, Shaobo Wang, Daixi Li, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 6, pp. 1545-1554
Closed Access | Times Cited: 75

Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic Nanoparticles
Manjing Li, Zhaojian Xu, Lu Zhang, et al.
ACS Nano (2021) Vol. 15, Iss. 6, pp. 9808-9819
Closed Access | Times Cited: 74

Cytokine-scavenging nanodecoys reconstruct osteoclast/osteoblast balance toward the treatment of postmenopausal osteoporosis
Yang Zhou, Yekun Deng, Zhongmin Liu, et al.
Science Advances (2021) Vol. 7, Iss. 48
Open Access | Times Cited: 72

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
Srinivasa Reddy Bonam, Niranjan G. Kotla, Raghvendra A. Bohara, et al.
Nano Today (2020) Vol. 36, pp. 101051-101051
Open Access | Times Cited: 69

Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
Qingqin Tan, Lingjie He, Xiaojun Meng, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 68

Page 1 - Next Page

Scroll to top